Sanofi $SNY Stock Position Raised by Evergreen Capital Management LLC

Evergreen Capital Management LLC lifted its position in Sanofi (NASDAQ:SNY) by 37.1% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 45,636 shares of the company’s stock after acquiring an additional 12,347 shares during the quarter. Evergreen Capital Management LLC’s holdings in Sanofi were worth $2,212,000 as of its most recent filing with the SEC.

Other hedge funds have also made changes to their positions in the company. CSM Advisors LLC purchased a new stake in shares of Sanofi in the third quarter worth approximately $18,244,000. Caprock Group LLC purchased a new stake in shares of Sanofi in the third quarter worth approximately $1,347,000. Natixis Advisors LLC lifted its position in shares of Sanofi by 11.8% in the third quarter. Natixis Advisors LLC now owns 3,113,381 shares of the company’s stock worth $146,952,000 after purchasing an additional 327,569 shares in the last quarter. Assetmark Inc. lifted its position in shares of Sanofi by 25.0% in the third quarter. Assetmark Inc. now owns 357,172 shares of the company’s stock worth $16,859,000 after purchasing an additional 71,356 shares in the last quarter. Finally, XY Capital Ltd purchased a new stake in shares of Sanofi in the third quarter worth approximately $1,603,000. Hedge funds and other institutional investors own 14.03% of the company’s stock.

Sanofi Price Performance

NASDAQ SNY opened at $46.90 on Thursday. Sanofi has a fifty-two week low of $43.32 and a fifty-two week high of $55.73. The stock’s 50-day moving average is $46.39 and its two-hundred day moving average is $48.00. The company has a debt-to-equity ratio of 0.20, a current ratio of 1.09 and a quick ratio of 0.73. The firm has a market cap of $114.39 billion, a P/E ratio of 13.03, a price-to-earnings-growth ratio of 1.17 and a beta of 0.42.

Sanofi Increases Dividend

The business also recently announced an annual dividend, which will be paid on Wednesday, June 3rd. Shareholders of record on Monday, May 4th will be issued a dividend of $2.4225 per share. This represents a yield of 502.0%. This is an increase from Sanofi’s previous annual dividend of $2.04. The ex-dividend date is Monday, May 4th. Sanofi’s dividend payout ratio is 44.44%.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on the company. Citigroup reaffirmed a “neutral” rating on shares of Sanofi in a research note on Monday, April 13th. Bank of America downgraded Sanofi from a “buy” rating to a “neutral” rating in a research note on Thursday, February 12th. Barclays downgraded Sanofi from an “overweight” rating to an “equal weight” rating in a research note on Tuesday, January 6th. TD Cowen reaffirmed a “hold” rating on shares of Sanofi in a research note on Tuesday, December 30th. Finally, Wall Street Zen downgraded Sanofi from a “strong-buy” rating to a “buy” rating in a research note on Saturday, February 21st. One analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and nine have issued a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $54.00.

Sanofi Profile

Sanofi (NASDAQ:SNY) is a multinational pharmaceutical company headquartered in France that researches, develops, manufactures and markets prescription medicines, vaccines and consumer healthcare products. The company operates across multiple therapeutic areas, including immunology, rare diseases, oncology, cardiovascular and metabolic diseases, and vaccines through its Sanofi Pasteur division. Sanofi sells products to hospitals, clinics, governments and retail pharmacies, with a broad global footprint and significant presence in Europe, North America and emerging markets.

Key commercial offerings include specialty biologics and established small-molecule medicines.